Inventiva IVA
NASDAQ IVA
$3.87 -0.08 (-2.02%)
As of: Nov 11, 2026 · 9:55 AM EST

Inventiva (IVA) Return on Equity [ROE] (2021)

Updated

Inventiva's Return on Equity [ROE] was -1991.44% in FY2023, down 1918.37 percentage points from -73.07% in FY2022.

Analysis

Inventiva (IVA) Return on Equity [ROE] (2021) Analysis & Trends

From FY2019 onward, Inventiva has reported Return on Equity [ROE] for 5 years.

  • Return on Equity [ROE] has now declined for three consecutive years, with a four-year change of -1934.62 percentage points (FY2019 to FY2023).
  • The FY2023 figure marks the lowest annual Return on Equity [ROE] in data going back to FY2019.
  • Per Business Quant data, Return on Equity [ROE] in earlier years was -73.07% in FY2022 (-22.47 pp), -50.61% in FY2021 (-6.31 pp), -44.29% in FY2020 (+12.53 pp) and -56.82% in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Inventiva 763.29 Mn 38.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -40.09%
API Access

Inventiva Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IVA&period=max&api_key=YOUR_API_KEY